C3 and age-related macular degeneration: The most widely accepted mechanism by which the CFH Y402H variant increases the risk for AMD involves its reduced ability to inhibit extracellular C3 activation, resulting in chronic inflammation and damage to eye tissue, including RPE and choroid [6].